Dr Joseph Anthony Dieterle Jr, DO | |
112 First St., Oxford, MD 21654-0532 | |
(410) 226-0013 | |
(410) 226-0013 |
Full Name | Dr Joseph Anthony Dieterle Jr |
---|---|
Gender | Male |
Speciality | Pediatrics |
Location | 112 First St., Oxford, Maryland |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1467475202 | NPI | - | NPPES |
2290502 | Medicaid | NJ |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208000000X | Pediatrics | H0060132 (Maryland) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Joseph Anthony Dieterle Jr, DO Box 532, 112 First St., Oxford, MD 21654-0532 Ph: (410) 226-0013 | Dr Joseph Anthony Dieterle Jr, DO 112 First St., Oxford, MD 21654-0532 Ph: (410) 226-0013 |
News Archive
Only 1 in 10 older adults in a large national survey who were found to have cognitive impairment consistent with dementia reported a formal medical diagnosis of the condition.
Blood on your toothbrush can be a warning sign of gum disease. And, if you are overweight, it can indicate other serious health issues, such as diabetes, heart disease and high blood pressure.
BioSante Pharmaceuticals, Inc. today announced that a New Drug Application (NDA) has been accepted for filing by the U.S. Food and Drug Administration (FDA) following submission in January 2011 by a subsidiary of Teva Pharmaceutical Industries Ltd.. The FDA has assigned a PDUFA date of November 14, 2011. The PDUFA date is the target date for the FDA to complete its review of the NDA.
Half-matched bone marrow or stem cell transplants for blood cancer patients have typically been associated with disappointing clinical outcomes. However, a clinical trial conducted at the Kimmel Cancer Center at Jefferson testing its unique, two-step half-match procedure has produced some promising results: the probability of overall survival was 45 percent in all patients after three years and 75 percent in patients who were in remission at the time of the transplant.
› Verified 5 days ago